UCB, Inc., is a global biopharmaceutical company committed to developing innovative
treatments for inflammatory diseases such as CD. UCB is dedicated to creating unique
programs and tools to help people with Crohn’s fulfill their educational ambitions.
We are proud to sponsor a scholarship program that recognizes and rewards your ability
to take control of Crohn's—and not allow it to control you.
In 2013, UCB will award 20 one-time scholarships of up to $5,000 each to individuals diagnosed with Crohn's disease.
Read about Past Crohn's Scholarship Recipients